Survivorship

Breast Cancer

Adherence to Tamoxifen Therapy Declines in Male Patients With Breast Cancer

By

Jennifer Larson

Researchers conducted a population-based cohort study to better understand the risk factors for endocrine therapy discontinuation and nonadherence among men with hormone-positive breast cancer.

Side-Effect Management

Cancer Pain Self-Management Support Not Meeting Patient Needs, Preferences

By

Jennifer Larson

Researchers surveyed patients with cancer to determine whether cancer pain self-management support meets their needs and preferences during the transition to home and self-care.

Prostate Cancer

Strategies for Managing Chronic Pain in Patients With Bone-Metastatic CRPC

By

Bryant Furlow

An overview of prostate cancer metastases to bone is presented, including strategies for pain assessment and palliative radiotherapy.

Breast Cancer

Breast Cancer-Related Psychological Distress Greater at Safety Net Hospitals

By

Jennifer Larson

Researchers sought to measure psychological distress in patients at a safety net hospital, where language, cultural, and access barriers are more common.

Side-Effect Management

The Role of Pharmacogenetics in Ondansetron Failure in Pediatric Patients with CINV

By

Jennifer Larson

Researchers sought to determine what genetic factors may prompt a refractory response to ondansetron in pediatric patients with cancer.

Hematologic Cancers

Predictors of 28-Day Mortality Due to Septic Shock With Hematologic Malignancies

By

Jennifer Larson

Researchers sought to determine predictors for survival among hematologic cancer patients with septic shock.

Myeloproliferative Neoplasms

Higher Symptom Burden More Likely to Improve With MPN Treatment

By

Vicki Moore, PhD

Analysis of data from 2 clinical trials sought to determine the effect on symptom burden of 2 common therapies for myeloproliferative neoplasms.

Brain Cancer

No Benefit Seen With Armodafinil for Fatigue in Patients With High-Grade Glioma

By

Vicki Moore, PhD

Treatment of fatigue related to high-grade glioma using armodafinil did not show a meaningful benefit over placebo in a phase 3 trial.

General Oncology

Sitting, Inactivity Increase Death Risk Among Cancer Survivors

Risk for both all-cause and cancer-specific death increased for cancer survivors with combination of prolonged sitting and inactivity.

Lung Cancer

Incidence of Advanced Lung Cancer Continues to Decline in the U.S.

During 2014 to 2018, incidence continued to increase slowly for female breast cancer, remained stable for prostate cancer